SCHEMBL3652622

SCHEMBL3652622

O=C(NCc1cccs1)c1cccnc1SCCS(=O)(=O)c1ccc(F)c(F)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.69
▸ KMT2A Q03164 6/20 0.65
▸ LMNA P02545 3/20 0.65
▸ KDM4E B2RXH2 3/20 0.48
▸ HPGD P15428 5/20 0.47
▸ MAPT P10636 5/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ HSD17B10 Q99714 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ GRK2 P25098 1/20 0.41
▸ PTPN7 P35236 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ CTDSP1 Q9GZU7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3646193 0.90 ALDH1A1 (0.73) ALDH1A1KMT2ALMNAKDM4EHPGD
SCHEMBL3646877 0.90 ALDH1A1 (0.69) ALDH1A1KMT2ALMNAKDM4EHPGD
SCHEMBL3649195 0.88 ALDH1A1 (0.73) ALDH1A1KMT2ALMNAKDM4EHPGD
SCHEMBL3649724 0.87 ALDH1A1 (0.77) ALDH1A1KMT2ALMNAKDM4EHPGD
SCHEMBL3650903 0.87 ALDH1A1 (0.81) ALDH1A1KMT2ALMNAKDM4EHPGD
SCHEMBL4176481 0.86 ALDH1A1 (0.76) ALDH1A1KMT2ALMNAKDM4EHPGD
SCHEMBL3647879 0.86 ALDH1A1 (0.75) ALDH1A1KMT2ALMNAKDM4EHPGD
SCHEMBL3650577 0.86 ALDH1A1 (0.72) ALDH1A1KMT2ALMNAKDM4EHPGD
SCHEMBL3653240 0.86 ALDH1A1 (0.72) ALDH1A1KMT2ALMNAKDM4EHPGD
SCHEMBL3644156 0.85 ALDH1A1 (0.68) ALDH1A1KMT2ALMNAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084470-B2 Substituted nicotinamide compounds and uses thereof GRUENENTHAL GMBH (DE) 2011-12-27 — — US claimed
EP-2188258-A1 SUBSTITUTED NICOTINAMIDE COMPOUNDS AND THE USE THEREOF IN PHARMACEUTICAL PRODUCTS Grünenthal GmbH (DE) 2010-05-26 — — EP claimed
WO-2009036938-A1 SUBSTITUTED NICOTINAMIDE COMPOUNDS AND THE USE THEREOF IN PHARMACEUTICAL PRODUCTS Grünenthal GmbH (DE) 2009-03-26 — — WO claimed
US-20090076086-A1 SUBSTITUTED NICOTINAMIDE COMPOUNDS AND USES THEREOF GRUENENTHAL GMBH (DE) 2009-03-19 — — US claimed
US-8084470-B2 Substituted nicotinamide compounds and uses thereof GRUENENTHAL GMBH (DE) 2011-12-27 — — US disclosed
EP-2188258-A1 SUBSTITUTED NICOTINAMIDE COMPOUNDS AND THE USE THEREOF IN PHARMACEUTICAL PRODUCTS Grünenthal GmbH (DE) 2010-05-26 — — EP disclosed
WO-2009036938-A1 SUBSTITUTED NICOTINAMIDE COMPOUNDS AND THE USE THEREOF IN PHARMACEUTICAL PRODUCTS Grünenthal GmbH (DE) 2009-03-26 — — WO disclosed
US-20090076086-A1 SUBSTITUTED NICOTINAMIDE COMPOUNDS AND USES THEREOF GRUENENTHAL GMBH (DE) 2009-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076086-A1 SUBSTITUTED NICOTINAMIDE COMPOUNDS AND USES THEREOF NNT, NAMPT, NADK ALDH1A1 281/4885KMT2A 1677/4885LMNA 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback